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Abstract
Background—Depression and stress have each been found to be associated with poor prognosis 
in coronary heart disease (CHD) patients. A recently offered ‘Psychosocial Perfect Storm’ 
conceptual model hypothesizes amplified risk will occur in those with concurrent stress and 
depressive symptoms. We tested this hypothesis in a large sample of U.S. adults with CHD.
Methods and Results—Participants included 4487 adults with CHD from the REasons for 
Geographic and Racial Differences in Stroke (REGARDS) study, a prospective cohort study of 
30,239 Black and White adults. We conducted Cox proportional hazards regression with the 
composite outcome of myocardial infarction (MI) or death and adjustment for demographic, 
clinical, and behavioral factors. Overall, 6.1% reported concurrent high stress and high depressive 
symptoms at baseline. Over a median 5.95-years of follow-up, 1,337 events occurred. In the first 
2.5-years of follow-up, participants with concurrent high stress and high depressive symptoms had 
increased risk for MI or death (adjusted hazard ratio [HR]=1.48, [95% CI: 1.08–2.02]) relative to 
those with low stress and low depressive symptoms. Those with low stress and high depressive 
symptoms (HR=0.92, [95% CI: 0.66–1.28]) or high stress and low depressive symptoms 
(HR=0.86, [95% CI: 0.57–1.29]) were not at increased risk. The association on MI or death was 
not significant after the initial 2.5-years of follow-up (HR=0.89, [95% CI: 0.65–1.22]).
Conclusions—Our results provide initial support for a ‘Psychosocial Perfect Storm’ conceptual 
model; the confluence of depressive symptoms and stress on medical prognosis in adults with 
CHD may be particularly destructive in the shorter-term.
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Stress and depression are each associated with increased risk for incident and recurrent 
coronary heart disease (CHD),1–19 but the two likely have a complex inter-relationship,20 
and only a limited number of prior studies have investigated their effect on risk for 
myocardial infarction (MI) and mortality when both are present. In one of the largest cross-
national studies on this topic, adults who reported permanent home/work stress and 
depression had a two-fold higher odds for a history of MI when compared to their never 
stressed and not depressed counterparts.21 Relatedly, extant research on the conjoint effect 
of anxiety and depression on adverse cardiac outcomes has produced conflicting results. The 
presence of both depression and anxiety were associated with increased risk for recurrent 
MI, cardiovascular death, or all-cause mortality in some studies,22–25 while others have not 
found evidence of higher cardiovascular risk in the presence of both psychosocial 
factors.26, 27 A recent conceptual model of the occurrence of an MI used a Perfect Storm 
metaphor to note that MIs are not caused by a single or a few factors, but rather result from 
the confluence of many situations and underlying risk factors.28 We have recently presented 
a Psychosocial Perfect Storm model of MI and mortality, and have suggested that it may 
take an underlying chronic psychosocial vulnerability, such as depression, in the presence of 
a more transient situation or trigger, such as psychological stress, for clinical events to 
occur.29
We tested our Psychosocial Perfect Storm29 model for understanding CHD prognosis by 
examining whether the confluence of high stress and high depressive symptoms amplifies 
shorter-term risk (< 2.5-years) for MI or death in individuals with CHD. We hypothesized 
that among individuals with CHD, those with concurrent high stress and high depressive 
symptoms would exhibit an increased risk of MI or death while their counterparts with high 
stress only or depressive symptoms only would not have an increased risk of MI or death.
Methods
Data Source and Sample
The REasons for Geographic and Racial Differences in Stroke (REGARDS) study is 
examining the reasons for higher stroke mortality among blacks and residents of the 
Southeastern United States (US). CHD outcomes are being obtained with support from an 
ancillary study (REGARDS-MI).30 Details of the REGARDS study have been described in 
detail previously.31 In brief, 30,239 Black and White adults ≥ 45 years of age from 
throughout the continental US were enrolled between January 2003 and October 2007. 
Blacks and residents of the stroke buckle (coastal North Carolina, South Carolina and 
Georgia) and stroke belt (the remainder of North Carolina, South Carolina and Georgia and 
Alabama, Mississippi, Louisiana, Tennessee and Arkansas) were over-sampled. The current 
analysis was limited to REGARDS study participants with a history of CHD at baseline 
defined as a self-reported history of MI or coronary revascularization procedure 
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(percutaneous coronary interventions or coronary artery bypass grafting) or evidence of MI 
on the study electrocardiogram.
Of the 5,314 participants with a history of CHD, we excluded 28 participants who were 
missing data on depressive symptoms or perceived stress at baseline, 81 participants who 
were missing follow-up data for outcomes, and 718 participants who were missing covariate 
information, leaving 4,487 participants for analysis. The Institutional Review Boards at the 
participating centers approved the REGARDS study protocol, and all participants provided 
written informed consent.
Data Collection
Baseline data were collected through a computer-assisted telephone interview, an in-home 
examination, and a self-administered questionnaire. Information was collected on 
demographics, education, income, alcohol consumption, marital status, general self-rated 
health, cigarette smoking, physical activity and medication adherence during the telephone 
interview. The in-home examination was conducted by trained health professionals and 
included a physical examination, collection of biological samples and a pill bottle review. 
For the pill bottle review, participants were asked to provide all prescription and non-
prescription medications they had taken in the past two weeks prior to the in home-
examination and medication names were recorded and coded into drug classes. During the 
in-home examination, an electrocardiogram was performed.
Depressive symptoms
The 4-item Center for Epidemiologic Studies Depression (CES-D) scale, collected as part of 
the computer-assisted telephone interview, was used to assess depressive symptoms. The 
four scale items assess how often over the prior week the participant felt depressed, felt 
lonely, had crying spells and felt sad; as such these 4-items assess cognitive and not somatic 
symptoms of depression. Response options for each item were less than 1 day (no points), 
1–2 days (1 point), 3–4 days (2 points) and 5–7 days (3 points). After summing the points 
from the four items, high depressive symptoms were defined as having a score ≥ 4. This 
definition has been found in previous studies to have 79.2% sensitivity and 81.2% 
specificity when compared to depressive symptoms on the 20-item CES-D.32, 33 The 
internal consistency of the 4-item CES-D in this sample was high (α = 0.82).
Perceived stress
Perceived stress was ascertained using the 4-item version of the Perceived Stress Scale 
(PSS) as part of the computer-assisted telephone interview.34 The PSS assesses the degree to 
which participants felt they were unable to control important things in their life, confidence 
in their ability to handle personal problems, how often they felt that things were going their 
way and how often difficulties were overwhelming over the past month. Each of the four 
items is scored using a 4-point scale resulting in an overall score that can range from 0 to 16 
with higher scores indicating the presence of more stress. There is no accepted cut-point for 
defining high stress on the PSS. In primary analyses, high stress was defined as a PSS ≥ 8 in 
order to achieve a prevalence similar to high depressive symptoms. In secondary analyses, 
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high stress was defined as a PSS ≥ 7 to approximate the highest 20% of scores. The internal 
consistency of the 4-item PSS in this sample was acceptable (α = 0.68).
Covariates
We included demographics, region of residence, CHD risk factors, health behaviors, and 
medication use, ascertained at baseline as covariates. Self-reported race, age, sex, region of 
residence, education (less than high school education vs. at least a high school diploma), 
income (<$20,000 vs. ≥$20,000), marital status (married vs. not married), and general self-
rated health (excellent vs. very good, good, fair or poor) were included as covariates. We 
adjusted for region of residence because of the oversampling of REGARDS study 
participants in the stroke belt and stroke regions of the US. Heavy alcohol consumption was 
defined as > 14 alcoholic beverages per week for men (> 7 for women). Current smoking 
was defined as responding affirmatively to the following questions “Have you smoked at 
least 100 cigarettes in your lifetime?” and “Do you smoke cigarettes now, even 
occasionally?” Physical inactivity was defined as answering “none” to the question “How 
many times per week do you engage in intense physical activity, enough to work up a 
sweat?” Level of medication adherence was assessed using the 4-item Morisky Medication 
Adherence Scale (MMAS).35 Participants who reported poor medication taking behaviors 
on ≥ 2 of the items on the MMAS were categorized as having low adherence. Height and 
weight, measured during the study visit, were used to calculate body mass index (BMI). 
Blood pressure was measured two times and hypertension was defined as systolic blood 
pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, and/or self-reported use of 
antihypertensive medication. Diabetes was defined as a serum glucose ≥ 126 mg/dL for 
participants who had fasted prior to their in-home study visit, serum glucose ≥ 200 mg/dL 
for participants who had not fasted, or self-report of a prior diagnosis of diabetes with 
current use of insulin or oral hypoglycemic medications. History of stroke was based on 
self-report.
Outcomes
The outcomes for the current study included definite/probable MI or death from any cause. 
Outcome data through December 31, 2011 were used in this analysis. Following the in-home 
examination, participants were contacted twice yearly by telephone to identify potential 
events. When a cardiac-related hospitalization was reported, medical records were retrieved 
and reviewed by a team of trained physicians using a standardized protocol.36, 37 Follow-up 
time was recorded as the number of days from the baseline in-home visit to the first 
occurrence of a participant’s confirmed date of death, occurrence of a definite or probable 
MI, their last REGARDS study telephone contact, or December 31, 2011. Expert-
adjudicated definite MI was defined by review of medical records for the presence of 
ischemic signs or symptoms38, 39 and for positive diagnostic enzymes on electrocardiogram. 
Probable MIs were defined as those with elevated but not diagnostic enzymes with a 
positive but not diagnostic electrocardiogram; or with a positive electrocardiogram if 
enzymes were missing. Deaths were defined by report of next of kin or through online 
sources (e.g., Social Security Death index) and then confirmed by death certificates.30 
Cardiovascular death was examined in a secondary analysis. Using adjudicated outcomes, 
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cardiovascular death was defined as fatal MI, fatal stroke, fatal heart failure, and other fatal 
cardiovascular-related deaths.
Statistical Analyses
REGARDS participants were categorized into four mutually exclusive groups: low stress 
and low depressive symptoms, high stress and low depressive symptoms, low stress and 
high depressive symptoms, and having both high stress and high depressive symptoms.
Characteristics of REGARDS study participants with a history of CHD were calculated for 
participants in each of these four groups. We examined the association of high depressive 
symptoms and high stress, separately, and then jointly on MI or death. Analyses for the 
composite outcome of MI or death were conducted first, then, identical analyses were 
conducted for MI and for death, separately. Incidence rates were calculated per 1,000 
person-years of follow-up. Hazard ratios (HR) were calculated with three progressive levels 
of adjustment: Model 1 adjusted for race, sex, region of residence (stroke buckle, stroke belt, 
non-belt), BMI, income, education, marital status, general self-rated health, hypertension, 
diabetes, history of myocardial infarction and history of stroke; Model 2 additionally 
adjusted for use of statins, beta blockers, aspirin, antidepressants, clopidogrel and renin 
angiotensin system inhibitors; Model 3 additionally adjusted for health risk behaviors 
including heavy alcohol consumption, cigarette smoking, physical inactivity, and low 
medication adherence. The multiplicative interaction between high stress and high 
depressive symptoms on outcomes was determined in regression models including main 
effects for high stress and depressive symptoms and an interaction term (high stress * high 
depressive symptoms). The proportionality assumption of the Cox regression model was 
assessed by modeling changes in the HR associated with high stress and high depressive 
symptoms over follow-up time. The proportionality assumption was violated, indicating that 
the HRs were not constant over time. Therefore, separate Cox models were fitted for 
different follow-up time intervals. Consequently, HRs are presented separately for the first 
2.5 years of follow-up and follow-up beyond 2.5 years. This cut-point was chosen as ~50% 
of MIs or deaths occurred during the first 2.5 years of follow-up. In sensitivity analyses, 
follow-up time was dichotomized at 2 years, and separately, at 3 years.
To assess whether our results were robust to the cut-point chosen for defining high stress, 
we conducted a sensitivity analysis using PSS ≥7 to define high stress. We also used 
multiple imputation to explore the consistency of our results after accounting for participants 
with missing covariate information (n=718). For this analysis, 10 data sets were imputed 
with chained equations. Multiple imputation was based on observed values from all of the 
covariates included in the fully-adjusted Cox regression models and the outcome.40, 41 
Additionally, to better understand the association of high stress and depressive symptoms 
with cardiovascular disease, we conducted a supplemental analysis with cardiovascular 
death as the outcome. Analyses were conducted using SAS 9.3 (SAS Institute, Cary, NC). 
STATA 13.1 (StataCorp LP, College Station, TX) was used for multiple imputation. The 
significance level was set at P <0.05 for two-sided analyses.
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Participant Characteristics by Stress and Depressive Symptoms Group
Overall, 11.7% (n = 527) had high stress and 13.8% (n = 621) participants had high 
depressive symptoms. The prevalence of high stress only was 5.6% (n = 253) and the 
prevalence of high depressive symptoms only was 7.7% (n = 347), while the prevalence of 
concurrent high stress and high depressive symptoms at baseline was 6.1% (n = 274). The 
correlation between the scores on the stress scale (PSS) and the depressive symptoms scale 
(CES-D) was moderately high r = 0.52. Baseline characteristics by stress and depressive 
symptoms group are presented in Table 1. Mean age, BMI, and most demographic measures 
varied across stress and depressive symptoms groups. Prevalence of medical comorbidities 
(stroke, hypertension) and health risk behaviors (smoking, physical inactivity, and 
medication adherence) also varied by stress and depressive symptoms groups, with the 
highest prevalence of these medical conditions and health risk behaviors observed among 
those in the high stress and high depressive symptoms subgroup.
Association of Stress and Depressive Symptoms with MI or Death
Over a median 5.95-years of follow-up, 1,337 events (1,094 deaths and 614 MI events) 
occurred (Supplemental Table 1). Participants with high stress had a marginally higher risk 
for MI or death in the first 2.5 years of follow-up than participants with low stress 
(HR=1.22, [95% Confidence Interval [CI]: 0.94–1.57]) (Table 2). Similarly, participants 
with high depressive symptoms relative to those with low depressive symptoms had a higher 
risk for MI or death (HR=1.30, 95% CI: 1.02–1.64). After the initial 2.5-years of follow-up, 
no statistically significant association was present for high stress, or for high depressive 
symptoms, with MI or death.
Joint presence of high stress and high depressive symptoms—The incidence 
rate for MI or death was 42.8, 42.2, 51.4 and 77.5 per 1,000 person-years in the low stress 
and low depressive symptoms group, high stress and low depressive symptoms group, low 
stress and high depressive symptoms group, and concurrent high stress and high depressive 
symptoms group, respectively (Supplemental Table 2). After adjustment for age, race, sex, 
region of residence, BMI, income, education, marital status, general self-rated health, 
hypertension, diabetes, history of myocardial infarction and stroke and during the first 2.5 
years of follow-up, participants with concurrent high stress and high depressive symptoms 
relative to participants with low stress and low depressive symptoms had an increased risk 
of MI or death (Table 3) (HR = 1.64, 95% CI: 1.20–2.24). In contrast, those with low stress 
and high depressive symptoms (HR = 1.03, [95% CI: 0.74–1.42]), and those with high stress 
and low depressive symptoms (HR = 0.83, [95% CI: 0.55–1.25]) were not at increased risk 
for MI or death (Figure 1). These associations remained present after further multivariable 
adjustment. In the full multivariable adjusted model, the p-value for the high stress * high 
depressive symptoms interaction term during the first 2.5 years of follow-up was 0.04. After 
the initial 2.5-year follow-up period, concurrent high stress with high depressive symptoms 
were not significantly associated with MI or death. The interaction between high stress * 
high depressive symptoms was not statistically significant after 2.5 years of follow-up 
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(p=0.66). Results were similar when follow-up time was dichotomized at 2 years 
(Supplemental Table 2) and 3 years (Supplemental Table 3).
Individual Outcomes
High stress and high depressive symptoms, separately and jointly, were not associated with 
risk of MI during the first 2.5 years or beyond 2.5 years of follow-up (Supplemental Tables 
4 and 5; Figure 2). When examined individually, high depressive symptoms were associated 
with an increased risk of death in the first 2.5 years of follow-up in models with minimal 
adjustment for confounders (Supplemental Table 6; Figure 3). This association was 
attenuated after full multivariable adjustment. Only those with both high stress and high 
depressive symptoms had an increased risk for death in the first 2.5 years of follow-up, 
although the interaction term was not statistically significant (Supplemental Table 7). 
Consistent with our main results, high stress and high depressive symptoms, separately and 
jointly, were not associated with risk of death after the first 2.5 years of follow-up.
Sensitivity Analyses
The HRs for MI/death associated with high stress and high depressive symptoms did not 
change appreciably when PSS ≥ 7 score was used to define high stress (Supplemental Table 
8). Similarly, point estimates with the multiple imputation analysis did not change 
appreciably (Supplemental Table 9). During the first 2.5 years of follow-up and compared to 
participants with low stress and low depressive symptoms, the multivariable adjusted hazard 
ratio for cardiovascular death was 1.14 (95% CI 0.61 – 2.13), 0.89 (95% CI 0.51 – 1.56) and 
1.38 (95% CI 0.80 – 2.36) for participants with high stress and low depressive symptoms, 
low stress and high depressive symptoms, and high stress and high depressive symptoms 
(Supplemental Table 10; p-value for interaction = 0.53).
Discussion
Consistent with the Psychosocial Perfect Storm29 model, and prior research in this area,21 
our results demonstrate that the joint presence of high stress and high depressive symptoms 
compared to low stress and low depressive symptoms is associated with a 48% increased 
short-term risk for MI or death in a large sample of US adults with CHD. The heightened 
risk associated with concurrent high stress and high depressive symptoms was robust and 
consistent across models that adjusted for demographics, medical history, medication use, 
and health risk behaviors. We also show that the risk of MI or death associated with 
concurrent high stress and high depressive symptoms during the 2.5-year high vulnerability 
period is markedly higher than that of stress or depressive symptoms alone. Further, when 
we disaggregated the composite outcome, those with concurrent high stress and high 
depressive symptoms relative to their counterparts were at increased risk for death, but not 
MI; thus the combined effect of high stress and high depressive symptoms may be most 
pronounced for risk of death. Although not statistically significant, the point estimates 
suggest an elevated risk for cardiovascular death.
Prior studies have examined whether exposure to stress or the presence of depression, 
independent of each other, were associated with incident CHD or death, with some finding 
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support for an independent main effect of stress and depression,19 and others finding a main 
effect for one and not the other.27 In INTERHEART, a case-control study conducted in 52 
countries, depressed people who reported permanent stress at home or at work had higher 
odds of having ischemic heart disease when compared to their never stressed and not 
depressed counterparts.21 While prior studies have focused on the health risk associated with 
the confluence of both depression and anxiety,25 with up to a three-fold increased risk of 
cardiovascular death in some studies, our results provide initial empirical evidence of the 
applicability of the Psychosocial Perfect Storm29 model specifically for understanding the 
association of stress and depression to medical prognosis (specifically death, and potentially 
cardiovascular death) in people with established CHD.
The results from the current study imply that prior research using measures of stress or 
depressive symptoms likely overestimated the effect of each individual risk factor on 
medical prognosis and all-cause mortality when the other was not considered. Thus, within 
the field of behavioral cardiology, research should more consistently consider the combined, 
rather than independent, effect of psychosocial factors (such as depression and stress) on 
CHD prognosis. More importantly, our results highlight that the adverse health 
consequences, specifically death, associated with the joint presence of high stress and high 
depressive symptoms are particularly pronounced during an early high vulnerability period 
even after adjustment for known confounders, and may not exert an influence beyond that 
critical period. Indeed, a prior analysis of the REGARDS dataset found that the effect of 
high depressive symptoms on risk of MI or death was not sustained after adjustment for 
established behavioral confounders when this vulnerability period (< 2.5 years) was not 
considered.18
These findings serve as initial validation of dimensions of the Psychosocial Perfect Storm 
conceptual model, where the co-occurrence of multiple psychosocial risk factors each in 
tandem contribute to elevated risk for poor medical prognosis in adults with CHD. Our 
results indicate that the deleterious health consequences associated with concurrent high 
stress and high depressive symptoms in the past-month may be specific to death, and may be 
time dependent. However, we do not have any information on the persistence and course of 
the concurrent depressive symptoms - stress phenotype for REGARDS participants, and as 
such cannot account for the remitting and relapsing nature of depressive symptoms and 
stress over time. We also do not have information in REGARDS about specific 
pathophysiological pathways (i.e., thrombogenicity, coronary perfusion, arrhythmia) 
implicated in the Perfect Storm model.29 Thus, we are unable to determine whether the 
interaction of stress exposure (chronic vs. acute), depression, and specific 
pathophysiological pathways (i.e., thrombogenicity, coronary perfusion, arrhythmia) is 
particularly cardiotoxic. It is possible that the presence of all three factors-- psychosocial, 
behavioral, and pathophysiological-- in an early vulnerability period, confers greatest risk 
for cardiovascular events (recurrent MI, cardiovascular death), and that increased all-cause 
mortality risk is observed only when the confluence of two psychosocial factors are 
considered. Future research using the Perfect Storm framework should clarify whether 
specific combinations of psychosocial exposures (acute versus chronic stress, depression), 
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behaviors, and pathophysiologic factors, generate differential prognostic outcomes and risk 
estimates over time.
Limitations
Our study is not without limitations. First, the presence of stress and depressive symptoms 
was measured at a single time point. Future research should examine the conditions under 
which high depressive symptoms contribute to excess risk of MI and death (e.g., in the 
context of stress exposure, the persistence of stress exposure). Just as regional wall motion 
abnormalities are identified by echocardiography only under exercise or pharmacologic 
stress, it may be that psychosocial ‘stress’ in the depressed CHD patient reveals the 
mechanisms responsible for depression-related prognostic risk.29 Second, the REGARDS 
study is observational and we are unable to make causal inferences. We were also unable to 
conduct additional subgroup analyses because of the available sample size. Our 
supplementary analyses with the individual components of the composite outcome suggest 
that those with concurrent stress and depressive symptoms are at greatest risk for all-cause 
mortality, and potentially cardiovascular mortality, in the first 2.5 years; larger samples are 
required to explore these individual outcomes more definitively as we were underpowered. 
Future research should also replicate these findings in independent samples adequately 
powered to examine effect modification by levels of stress and depressive symptoms; to 
facilitate replication by independent researchers, we have included the initial REGARDS 
manuscript proposal as a supplemental file. While those with concurrent high stress and high 
depressive symptoms had the highest risk for adverse outcomes, this represented only 6% of 
the study sample, a small population subgroup. Thus, further work is needed to determine 
the net public health benefit of focusing on this potentially low probability occurrence. 
Third, health behaviors were assessed using self-report which is subject to reporting biases. 
Future research should use objective measures of health behaviors as opposed to self-report 
to determine if the Perfect Storm is partially explained by behavior. We also used a self-
report measure of general health as a proxy for overall medical comorbidity. Although self-
rated health is shown to be associated with mortality beyond provider assessments of 
health,42 future research in this area could benefit from use of a standardized instrument 
such as the Charlson comorbidity index to account for overall medical comorbidity and 
disease severity. Fourth, the 4-item version of the CES-D that was used in REGARDS 
assesses only cognitive symptoms of depression, and thus does not assess somatic symptoms 
of depression. Therefore, we are unable to determine whether specific clusters of depression 
symptoms in combination with high stress would yield similar estimates of prognostic risk.
Conclusion
The current results provide initial empirical evidence to support a Psychosocial Perfect 
Storm conceptual model for understanding how psychosocial variables might be associated 
with medical prognosis in people with established CHD.29 While the prevalence of 
concurrent high stress and high depressive symptoms was only 6.0% among REGARDS 
participants with established CHD, a low probability occurrence, the impact of the 
confluence of psychosocial risk factors on the overall burden of disease, and mortality risk, 
was high. In particular, we found that concurrent high stress and high depressive symptoms 
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was associated with an increased risk of MI or death, specifically death, in the first 2.5 years 
of follow-up, and that risk for outcomes was not elevated for participants with either of these 
conditions alone during this critical period. These results provide a challenge to traditional 
research paradigms that have focused on identifying if depression confers excess prognostic 
risk in post-MI patients, and instead places a newfound focus on identifying under what 
conditions poor prognosis occurs for CHD patients with high depressive symptoms, or 
conversely, that for stressed CHD patients, it requires the presence of depressive symptoms 
to indicate high mortality risk. The Psychosocial Perfect Storm model may inform research 
into the development, testing, and implementation of novel primary and secondary 
prevention strategies that focus on the treatment of stress and depression during this high 
vulnerability period. Thus, behavioral interventions that teach individuals with CHD how to 
adaptively manage stress and depressive symptoms during the high vulnerability period 
might be particularly important for lowering risk of death, and potentially cardiovascular 
death, in the shorter-term. By identifying the specific conditions under which depressed and 
stressed patients exhibit poor medical prognosis, we might also be better able to identify the 
modifiable mechanisms (biological, psychological, social, and environmental) by which 
depression and stress increase risk of MI and mortality and create targeted interventions to 
mitigate the excess risk.
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Table 2
Association of high stress and depressive symptoms evaluated separately on myocardial infarction or death, 
REGARDS (N = 4,487).
Hazard ratio (95% confidence interval)
Model 1 Model 2 Model 3
First 2.5 years of follow-up
High stress versus low stress 1.22 (0.94 – 1.57) 1.20 (0.93 – 1.55) 1.20 (0.93 – 1.55)
High depressive symptoms versus low depressive symptoms 1.30 (1.02 – 1.64) 1.22 (0.96 – 1.55) 1.16 (0.92 – 1.47)
> 2.5 years of follow-up
High stress versus low stress 1.03 (0.83 – 1.28) 1.01 (0.81 – 1.25) 1.01 (0.81 – 1.25)
High depressive symptoms versus low depressive symptoms 0.98 (0.80 – 1.21) 0.92 (0.75 – 1.13) 0.88 (0.72 – 1.09)
Model 1 adjusted for race, age, sex, region of residence, body mass index, income, education, marital status, general self-rated health, hypertension, 
diabetes, history of myocardial infarction and stroke.
Model 2 adjusted for all covariates in Model 1 and use of statins, beta blockers, aspirin, antidepressants, clopidogrel and renin angiotensin system 
inhibitors.
Model 3 adjusted for all in Model 1 and Model 2 and physical activity, alcohol consumption, cigarette smoking, and medication adherence.
REGARDS (Reason for Geographic and Racial Differences in Stroke).
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Table 3
Association of concurrent stress and depressive symptoms with myocardial infarction or death, REGARDS (N 
= 4,487).
Hazard ratio (95% confidence interval)
Model 1 Model 2 Model 3
First 2.5 years of follow-up
Low stress and low depressive symptoms 1 (ref) 1 (ref) 1 (ref)
High stress and low depressive symptoms 0.83 (0.55 – 1.25) 0.84 (0.56 – 1.27) 0.86 (0.57 – 1.29)
Low stress and high depressive symptoms 1.03 (0.74 – 1.42) 0.97 (0.70 – 1.35) 0.92 (0.66 – 1.28)
High stress and high depressive symptoms 1.64 (1.20 – 2.24) 1.54 (1.13 – 2.11) 1.48 (1.08 – 2.02)
p-value for interaction 0.03 0.03 0.04
> 2.5 years of follow-up
Low stress and low depressive symptoms 1 (ref) 1 (ref) 1 (ref)
High stress and low depressive symptoms 1.09 (0.82 – 1.44) 1.09 (0.82 – 1.44) 1.10 (0.83 – 1.46)
Low stress and high depressive symptoms 1.00 (0.78 – 1.29) 0.94 (0.73 – 1.21) 0.90 (0.70 – 1.16)
High stress and high depressive symptoms 0.98 (0.71 – 1.33) 0.91 (0.67 – 1.25) 0.89 (0.65 – 1.22)
p-value for interaction 0.65 0.65 0.66
Model 1 adjusted for race, age, sex, region of residence, body mass index, income, education, marital status, general self-rated health, hypertension, 
diabetes, history of myocardial infarction and stroke.
Model 2 adjusted for all covariates in Model 1 and use of statins, beta blockers, aspirin, antidepressants, clopidogrel and renin angiotensin system 
inhibitors.
Model 3 adjusted for all in Model 1 and Model 2 and physical activity, alcohol consumption, cigarette smoking, and medication adherence.
REGARDS (Reason for Geographic and Racial Differences in Stroke).
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